<p>全球市场正在应对复杂的局面，美国股指在波动的经济信号和劳动市场数据中经历了混合走势。在这种情况下，识别有前景的投资机会可能具有挑战性，但对于那些寻求低成本增长潜力的投资者来说，便宜股仍然提供了引人注目的可能性。尽管 “便宜股” 这个术语可能显得过时，这些较小或较新的公司在强大的财务支持和稳健的基本面下，往往呈现出独特的机会。</p>
<h3>全球十大便宜股</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>EZZ Life Science Holdings (ASX:EZZ)</td>
<td>A$2.17</td>
<td>A$102.84M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.61</td>
<td>HK$964.89M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>HSS Engineers Berhad (KLSE:HSSEB)</td>
<td>MYR0.63</td>
<td>MYR320.34M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.57</td>
<td>HK$2.15B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Angler Gaming (NGM:ANGL)</td>
<td>SEK3.60</td>
<td>SEK269.95M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Deleum Berhad (KLSE:DELEUM)</td>
<td>MYR1.46</td>
<td>MYR586.27M</td>
<td>✅ 5 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.17</td>
<td>SGD12.48B</td>
<td>✅ 5 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Begbies Traynor Group (AIM:BEG)</td>
<td>£1.17</td>
<td>£186.24M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Deceuninck (ENXTBR:DECB)</td>
<td>€2.11</td>
<td>€291.65M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Netgem (ENXTPA:ALNTG)</td>
<td>€0.93</td>
<td>€31.36M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们全球便宜股筛选器中的 3,739 只股票的完整列表。</p>
<p>下面我们展示了一些经过筛选的股票。</p>
<h2>大名城控股 (SHSE:600094)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 大名城控股有限公司在中国房地产开发领域运营，市值为人民币 73.9 亿元。</p>
<p><strong>运营：</strong> 该公司在中国的运营收入为人民币 45.3 亿元。</p>
<p><strong>市值：</strong> 人民币 73.9 亿元</p>
<p>大名城控股有限公司在中国房地产领域运营，市值为人民币 73.9 亿元，2025 年上半年收入为人民币 15.9 亿元，较去年有所增长，但净收入大幅下降至人民币 3340 万元。公司的财务健康状况复杂；尽管在五年内将债务与股本比率降低至令人满意的水平，但仍处于亏损状态，过去五年年均收益下降 58%。尽管每周波动稳定，管理层和董事会经验丰富，但在盈利能力和经营现金流的利息覆盖方面仍面临挑战。</p>
<ul>
<li>点击探索我们对大名城控股财务健康报告的详细分析。</li>
<li>在这里了解大名城控股的历史表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2bb8ed32-3923-49c7-a724-802dfdf5817b/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2bb8ed32-3923-49c7-a724-802dfdf5817b/chart/debt-equity-history-analysis"/></p>
<p>SHSE:600094 债务与股本历史及分析截至 2025 年 9 月</p>
<h2>中柱医疗控股有限公司 (SHSE:600568)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> 中柱医疗控股有限公司专注于中国药物的研究、开发、生产和销售，市值为人民币 36.9 亿元。</p>
<p><strong>运营：</strong> 中柱医疗控股有限公司没有具体的收入细分报告。</p>
<p><strong>市值：</strong> 人民币 36.9 亿元</p>
<p>中柱医疗控股有限公司市值为人民币 36.9 亿元，2025 年上半年收入为人民币 3.0285 亿元，较去年有所增长。尽管收入增加，净亏损减少至人民币 2414 万元，但公司仍处于亏损状态，过去五年年均亏损增长 23.9%。积极的一面是，公司无债务，短期资产（人民币 12 亿元）足以覆盖其长期（人民币 3740 万元）和短期负债（人民币 3.191 亿元）。由于正向自由现金流趋势，公司还受益于超过三年的稳定现金流。</p>
<ul>
<li>解锁我们对中柱医疗控股有限公司股票分析的全面见解，详见此财务健康报告。</li>
<li>查看中柱医疗控股有限公司的历史业绩报告，以了解其在往年中的表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis"/></p>
<p>SHSE:600568 财务状况分析截至 2025 年 9 月</p>
<h2>荣安地产有限公司 (SZSE:000517)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 荣安地产有限公司在中国开发和销售房地产，市值为人民币 62.4 亿元。</p>
<p><strong>运营：</strong> 公司的收入完全来自其在中国的运营，总额为人民币 259.8 亿元。</p>
<p><strong>市值：</strong> 人民币 62.4 亿元</p>
<p>荣安地产有限公司面临盈利下降的挑战，2025 年上半年收入大幅下降至人民币 39 亿元，较去年同期的人民币 138.8 亿元大幅减少，净收入从人民币 4.6403 亿元降至人民币 3645 万元。尽管处于亏损状态，但其债务水平令人满意，净债务与股本比率为 10.3%，并且短期资产覆盖超过其短期（人民币 187 亿元）和长期负债（人民币 16 亿元）。公司的董事会经验丰富，但在持续的财务压力下，其分红记录仍不稳定。</p>
<ul>
<li>点击这里访问我们完整的财务健康分析报告，以了解荣安地产有限公司的动态。</li>
<li>使用我们的详细历史业绩报告评估荣安地产有限公司的先前结果。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6b4612dc-7c91-4724-992e-729faa007fde/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6b4612dc-7c91-4724-992e-729faa007fde/chart/financial-position-analysis"/></p>
<p>SZSE:000517 财务状况分析截至 2025 年 9 月</p>
<h2>关键要点</h2>
<ul>
<li>在这里开始您的投资之旅，探索我们精选的 3,739 只全球便士股票。</li>
<li>对其他可能性感兴趣？我们发现 18 只美国股票预计明年将支付超过 6% 的股息收益率。查看完整列表，免费获取。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章不应被视为财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。</em></p>

大名城

大名城B

荣安地产

<p>全球市场呈现出混合走势，低价股成为潜在的投资机会。大名城、众筑医疗和荣安地产被强调为值得关注的低价股。大名城的市值为 73.9 亿人民币，但面临盈利挑战。众筑医疗的市值为 36.9 亿人民币，显示出收入增长，但仍未盈利。荣安地产的估值为 62.4 亿人民币，报告显示盈利和收入下降。尽管面临挑战，这些公司在当前市场环境中提供了独特的投资可能性</p>

<p>Global markets have been navigating a complex landscape, with U.S. equity indexes experiencing mixed movements amid fluctuating economic signals and labor market data. In this context, identifying promising investment opportunities can be challenging, yet penny stocks continue to offer intriguing possibilities for those seeking growth potential at lower entry points. Though the term 'penny stock' might seem outdated, these smaller or newer companies often present unique opportunities when supported by strong financials and sound fundamentals.</p>
<div class="lb-trans"><p>全球市场正在应对复杂的局面，美国股指在波动的经济信号和劳动市场数据中经历了混合走势。在这种情况下，识别有前景的投资机会可能具有挑战性，但对于那些寻求低成本增长潜力的投资者来说，便宜股仍然提供了引人注目的可能性。尽管 “便宜股” 这个术语可能显得过时，这些较小或较新的公司在强大的财务支持和稳健的基本面下，往往呈现出独特的机会。</p>
</div><h3>Top 10 Penny Stocks Globally</h3>
<div class="lb-trans"><h3>全球十大便宜股</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>EZZ Life Science Holdings (ASX:EZZ)</td>
<td>A$2.17</td>
<td>A$102.84M</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.61</td>
<td>HK$964.89M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>HSS Engineers Berhad (KLSE:HSSEB)</td>
<td>MYR0.63</td>
<td>MYR320.34M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.57</td>
<td>HK$2.15B</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Angler Gaming (NGM:ANGL)</td>
<td>SEK3.60</td>
<td>SEK269.95M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Deleum Berhad (KLSE:DELEUM)</td>
<td>MYR1.46</td>
<td>MYR586.27M</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.17</td>
<td>SGD12.48B</td>
<td>✅ 5 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Begbies Traynor Group (AIM:BEG)</td>
<td>£1.17</td>
<td>£186.24M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Deceuninck (ENXTBR:DECB)</td>
<td>€2.11</td>
<td>€291.65M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Netgem (ENXTPA:ALNTG)</td>
<td>€0.93</td>
<td>€31.36M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>股价</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益与风险</strong></td>
</tr>
<tr>
<td>EZZ Life Science Holdings (ASX:EZZ)</td>
<td>A$2.17</td>
<td>A$102.84M</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lever Style (SEHK:1346)</td>
<td>HK$1.61</td>
<td>HK$964.89M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>HSS Engineers Berhad (KLSE:HSSEB)</td>
<td>MYR0.63</td>
<td>MYR320.34M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>TK Group (Holdings) (SEHK:2283)</td>
<td>HK$2.57</td>
<td>HK$2.15B</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Angler Gaming (NGM:ANGL)</td>
<td>SEK3.60</td>
<td>SEK269.95M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Deleum Berhad (KLSE:DELEUM)</td>
<td>MYR1.46</td>
<td>MYR586.27M</td>
<td>✅ 5 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Yangzijiang Shipbuilding (Holdings) (SGX:BS6)</td>
<td>SGD3.17</td>
<td>SGD12.48B</td>
<td>✅ 5 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Begbies Traynor Group (AIM:BEG)</td>
<td>£1.17</td>
<td>£186.24M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Deceuninck (ENXTBR:DECB)</td>
<td>€2.11</td>
<td>€291.65M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Netgem (ENXTPA:ALNTG)</td>
<td>€0.93</td>
<td>€31.36M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 3,739 stocks from our Global Penny Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们全球便宜股筛选器中的 3,739 只股票的完整列表。</p>
</div><p>Underneath we present a selection of stocks filtered out by our screen.</p>
<div class="lb-trans"><p>下面我们展示了一些经过筛选的股票。</p>
</div><h2>Greattown Holdings (SHSE:600094)</h2>
<div class="lb-trans"><h2>大名城控股 (SHSE:600094)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Greattown Holdings Ltd. operates in the real estate development sector in China with a market capitalization of CN¥7.39 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 大名城控股有限公司在中国房地产开发领域运营，市值为人民币 73.9 亿元。</p>
</div><p><strong>Operations:</strong> The company generates revenue of CN¥4.53 billion from its operations within China.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司在中国的运营收入为人民币 45.3 亿元。</p>
</div><p><strong>Market Cap:</strong> CN¥7.39B</p>
<div class="lb-trans"><p><strong>市值：</strong> 人民币 73.9 亿元</p>
</div><p>Greattown Holdings Ltd. operates in China's real estate sector with a market cap of CN¥7.39 billion and generated revenue of CN¥1.59 billion for H1 2025, an increase from the previous year, though net income dropped significantly to CN¥33.4 million. The company's financial health is mixed; while it has reduced its debt-to-equity ratio over five years to a satisfactory level, it remains unprofitable with earnings declining by 58% annually over the past five years. Despite stable weekly volatility and experienced management and board teams, challenges persist in profitability and interest coverage by operating cash flow remains inadequate.</p>
<div class="lb-trans"><p>大名城控股有限公司在中国房地产领域运营，市值为人民币 73.9 亿元，2025 年上半年收入为人民币 15.9 亿元，较去年有所增长，但净收入大幅下降至人民币 3340 万元。公司的财务健康状况复杂；尽管在五年内将债务与股本比率降低至令人满意的水平，但仍处于亏损状态，过去五年年均收益下降 58%。尽管每周波动稳定，管理层和董事会经验丰富，但在盈利能力和经营现金流的利息覆盖方面仍面临挑战。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in Greattown Holdings' financial health report.</li>
<li>Learn about Greattown Holdings' historical performance here.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击探索我们对大名城控股财务健康报告的详细分析。</li>
<li>在这里了解大名城控股的历史表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/2bb8ed32-3923-49c7-a724-802dfdf5817b/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/2bb8ed32-3923-49c7-a724-802dfdf5817b/chart/debt-equity-history-analysis"/></p>
<p>SHSE:600094 Debt to Equity History and Analysis as at Sep 2025</p>
<div class="lb-trans"><p>SHSE:600094 债务与股本历史及分析截至 2025 年 9 月</p>
</div><h2>Zhongzhu Healthcare HoldingLtd (SHSE:600568)</h2>
<div class="lb-trans"><h2>中柱医疗控股有限公司 (SHSE:600568)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Zhongzhu Healthcare Holding Co., Ltd focuses on the research, development, production, and sale of drugs in China, with a market cap of CN¥3.69 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 中柱医疗控股有限公司专注于中国药物的研究、开发、生产和销售，市值为人民币 36.9 亿元。</p>
</div><p><strong>Operations:</strong> There are no specific revenue segments reported for Zhongzhu Healthcare Holding Co., Ltd.</p>
<div class="lb-trans"><p><strong>运营：</strong> 中柱医疗控股有限公司没有具体的收入细分报告。</p>
</div><p><strong>Market Cap:</strong> CN¥3.69B</p>
<div class="lb-trans"><p><strong>市值：</strong> 人民币 36.9 亿元</p>
</div><p>Zhongzhu Healthcare Holding Co., Ltd, with a market cap of CN¥3.69 billion, reported revenue of CN¥302.85 million for the first half of 2025, showing growth from the previous year. Despite this increase in revenue and a reduction in net loss to CN¥24.14 million, the company remains unprofitable with losses increasing over five years at 23.9% annually. Positively, it is debt-free and has sufficient short-term assets (CN¥1.2 billion) to cover both its long-term (CN¥37.4 million) and short-term liabilities (CN¥319.1 million). The company also benefits from a stable cash runway exceeding three years due to positive free cash flow trends.</p>
<div class="lb-trans"><p>中柱医疗控股有限公司市值为人民币 36.9 亿元，2025 年上半年收入为人民币 3.0285 亿元，较去年有所增长。尽管收入增加，净亏损减少至人民币 2414 万元，但公司仍处于亏损状态，过去五年年均亏损增长 23.9%。积极的一面是，公司无债务，短期资产（人民币 12 亿元）足以覆盖其长期（人民币 3740 万元）和短期负债（人民币 3.191 亿元）。由于正向自由现金流趋势，公司还受益于超过三年的稳定现金流。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Zhongzhu Healthcare HoldingLtd stock in this financial health report.</li>
<li>Examine Zhongzhu Healthcare HoldingLtd's past performance report to understand how it has performed in prior years.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对中柱医疗控股有限公司股票分析的全面见解，详见此财务健康报告。</li>
<li>查看中柱医疗控股有限公司的历史业绩报告，以了解其在往年中的表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/0a3cf580-900f-46c8-851b-02eca26e9944/chart/financial-position-analysis"/></p>
<p>SHSE:600568 Financial Position Analysis as at Sep 2025</p>
<div class="lb-trans"><p>SHSE:600568 财务状况分析截至 2025 年 9 月</p>
</div><h2>Rongan PropertyLtd (SZSE:000517)</h2>
<div class="lb-trans"><h2>荣安地产有限公司 (SZSE:000517)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Rongan Property Co., Ltd. develops and sells real estate properties in China, with a market cap of CN¥6.24 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 荣安地产有限公司在中国开发和销售房地产，市值为人民币 62.4 亿元。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived entirely from its operations in China, amounting to CN¥25.98 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入完全来自其在中国的运营，总额为人民币 259.8 亿元。</p>
</div><p><strong>Market Cap:</strong> CN¥6.24B</p>
<div class="lb-trans"><p><strong>市值：</strong> 人民币 62.4 亿元</p>
</div><p>Rongan Property Co., Ltd. faces challenges with declining earnings, reporting a significant drop in revenue to CN¥3.90 billion for the first half of 2025 from CN¥13.88 billion a year prior, and net income falling to CN¥36.45 million from CN¥464.03 million. Despite being unprofitable, it maintains satisfactory debt levels with a net debt to equity ratio of 10.3% and has strong short-term asset coverage exceeding both its short-term (CN¥18.7 billion) and long-term liabilities (CN¥1.6 billion). The company's board is experienced, though its dividend track record remains unstable amidst ongoing financial pressures.</p>
<div class="lb-trans"><p>荣安地产有限公司面临盈利下降的挑战，2025 年上半年收入大幅下降至人民币 39 亿元，较去年同期的人民币 138.8 亿元大幅减少，净收入从人民币 4.6403 亿元降至人民币 3645 万元。尽管处于亏损状态，但其债务水平令人满意，净债务与股本比率为 10.3%，并且短期资产覆盖超过其短期（人民币 187 亿元）和长期负债（人民币 16 亿元）。公司的董事会经验丰富，但在持续的财务压力下，其分红记录仍不稳定。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of Rongan PropertyLtd.</li>
<li>Assess Rongan PropertyLtd's previous results with our detailed historical performance reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们完整的财务健康分析报告，以了解荣安地产有限公司的动态。</li>
<li>使用我们的详细历史业绩报告评估荣安地产有限公司的先前结果。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6b4612dc-7c91-4724-992e-729faa007fde/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/6b4612dc-7c91-4724-992e-729faa007fde/chart/financial-position-analysis"/></p>
<p>SZSE:000517 Financial Position Analysis as at Sep 2025</p>
<div class="lb-trans"><p>SZSE:000517 财务状况分析截至 2025 年 9 月</p>
</div><h2>Key Takeaways</h2>
<div class="lb-trans"><h2>关键要点</h2>
</div><ul>
<li>Embark on your investment journey to our 3,739 Global Penny Stocks selection here.</li>
<li>Interested In Other Possibilities? We've found 18 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里开始您的投资之旅，探索我们精选的 3,739 只全球便士股票。</li>
<li>对其他可能性感兴趣？我们发现 18 只美国股票预计明年将支付超过 6% 的股息收益率。查看完整列表，免费获取。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们提供的评论基于历史数据和分析师预测，仅使用无偏见的方法，我们的文章不应被视为财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。</em></p>
</div>

全球便士股票：GREATTOWN 控股及另外两个值得关注